Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus*
References (19)
- et al.
The effects of prostaglandins, prostaglandin inhibitors and oxygen on the closure of the ductus arteriosus, pulmonary arteries and umbilical vessels in vitro
Prostaglandins
(1974) - et al.
Specificity and accuracy of echocardiographic and clinical criteria for diagnosis of patent ductus arteriosus in fluid-restricted infants
J Pediatr
(1981) - et al.
Risk factor analysis of intraventricular hemorrhage in low birthweight infants
J Pediatr
(1981) - et al.
The development of hemostasis in the human fetus and newborn infant
J Pediatr
(1971) - et al.
Sonographic classification of intracranial hemorrhage: A prognostic indicator of mortality, morbidity, and short-term neurologic outcome
J Pediatr
(1982) - et al.
Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study
J Pediatr
(1983) - et al.
Pharmacologic closure of the patent ductus arteriosus in the premature infant
N Engl J Med
(1976) - et al.
Diseases of coagulation: The platelet and vasculature
- et al.
Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants
J Clin Pharmacol
(1978)
There are more references available in the full text version of this article.
Cited by (0)
- *
Supported in part by HD-16292, March of Dimes, and the Academic Senate of UCSD, GCRC Division of Research Resources Grant RR00827.
Copyright © 1984 Published by Mosby, Inc.